In recent years, effective obesity treatments like Ozempic and Mounjaro have changed lives. These drugs mimic the effects of ...
News-Medical.Net on MSN
Do GLP-1 drugs cause cancer? New review says no, may even protect
A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...
Your pancreas, crucial for digestion and blood sugar, can signal distress through persistent abdominal pain, unexplained ...
Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...
An innovative ‘smart insulin’ may offer people living with type 1 diabetes improved treatment options to regulate blood glucose levels. This is the discovery of researchers at Indiana University, who ...
The fight against obesity has become one of the greatest medical challenges of the 21st century, with the World Health Organisation (WHO) warning that over one billion people worldwide including 880 ...
Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a lab-designed protein, possibly opening the door to a new treatment avenue ...
Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...
Doctors share six science-backed ways to protect your pancreas and the key warning signs that could signal something’s wrong.
As you go about your daily life, you’re probably paying very little heed to a long, hardworking organ that’s nestled behind ...
Dong-A ST and its affiliate Metavia announced on the 5th that they presented the results of the global Phase 1 clinical trial and new preclinical ...
The Company’s investigational small moleculeglucagon-like peptide-1 (“GLP-1”) receptor agonist (“RA”), BMF-650, demonstrated potent weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results